Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, ST...
FDA Drug Recall #D-0634-2022 — Class I — February 3, 2022
Recall Summary
| Recall Number | D-0634-2022 |
| Classification | Class I — Serious risk |
| Date Initiated | February 3, 2022 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | STAQ Pharma, Inc. |
| Location | Denver, CO |
| Product Type | Drugs |
| Quantity | n/a |
Product Description
Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0105-04.
Reason for Recall
Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A
Distribution Pattern
CO, OH, and TX.
Lot / Code Information
Lot Number: 21104221A, Expiration date: 05-22-2022
Other Recalls from STAQ Pharma, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0024-2026 | Class III | Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), In... | Oct 9, 2025 |
| D-0023-2026 | Class III | Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in ... | Oct 9, 2025 |
| D-0025-2026 | Class III | FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in... | Oct 9, 2025 |
| D-0147-2024 | Class II | ROPivacaine HCl 0.2% PF in Sodium Chloride 1,00... | Nov 29, 2023 |
| D-0633-2022 | Class I | HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in ... | Feb 3, 2022 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.